We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Polyoxometalate Catalyst Renders Nerve Agents Harmless

By HospiMedica International staff writers
Posted on 30 Apr 2019
Print article
Image: Dr. Anatoly Frenkel next to the XPS powder diffraction beamline (Photo courtesy of BNL).
Image: Dr. Anatoly Frenkel next to the XPS powder diffraction beamline (Photo courtesy of BNL).
A new study describes a polyoxometalate (POM) catalyst that decomposes nerve agents, eliminating their harmful and lethal effects.

Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.

By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.

“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”

“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”

Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.

Related Links:
Brookhaven National Laboratory
Stony Brook University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.